David Tepper
Appaloosa Management
David Tepper Boston Scientific Corp stake
total: 317
Appaloosa Management BSX trades
- Total transactions:
- 13
- New positions:
- 2
- Sold out:
- 2
- Added:
- 4
- Reduced:
- 5
- Held since:
- 2020 Q1
- Held for:
- 3 quarters
- Latest activity:
- 2020 Q4
According to 2026 Q2 report, David Tepper doesn't hold any Boston Scientific Corp (BSX) shares. To date, the estimated cost basis is nearly $34.81 for "buy" trades and estimated average "sell" price is $38.21. Appaloosa Management first purchased BSX in 2016 Q4, initially acquiring 550,000 shares. David Tepper later completely sold out the position and invested in Boston Scientific Corp again in 2020 Q1. Since the initial investment in Boston Scientific Corp (BSX), Appaloosa Management has made 12 more transactions.
When did David Tepper sell Boston Scientific Corp (BSX)?
David Tepper sold off the entire Boston Scientific Corp (BSX) position in 2020 Q4.
When did David Tepper buy Boston Scientific Corp (BSX)?
David Tepper first invested in Boston Scientific Corp (BSX) in 2016 Q4 at the reported quarter-end price of $21.63 per share.
What's the cost basis of Appaloosa Management's BSX stake?
The estimated cost basis for Boston Scientific Corp (BSX) stake is around $34.81 per share. This represents their average reported price* across all buy transactions
Estimated cost basis*
- Weighted AVG buy price:
- $34.81
- Weighted AVG sell price:
- $38.21
David Tepper's historical trades in Boston Scientific Corp
13 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2020 Q4
|
0.00%
|
$38.21
|
-100% (-787,500)
|
|||
|
2020 Q3
|
0.53%
|
$38.21
|
-17.11% (-162,500)
|
|||
|
2020 Q2
|
0.58%
|
$35.11
|
+726.09% (+835,000)
|
|||
|
2020 Q1
|
0.11%
|
$32.63
|
new
|
|||
|
2018 Q4
|
0.00%
|
$38.50
|
-100% (-853,875)
|
|||
|
2018 Q3
|
0.58%
|
$38.50
|
-66.23% (-1,674,263)
|
|||
|
2018 Q2
|
0.95%
|
$32.70
|
-35.35% (-1,382,600)
|
|||
|
2018 Q1
|
1.10%
|
$27.32
|
-18.23% (-871,945)
|
|||
|
2017 Q4
|
1.13%
|
$24.79
|
+27.44% (+1,029,817)
|
|||
|
2017 Q3
|
1.58%
|
$29.17
|
+65.70% (+1,487,966)
|
|||
|
2017 Q2
|
0.93%
|
$27.72
|
-32.19% (-1,075,100)
|
|||
|
2017 Q1
|
1.45%
|
$24.87
|
+507.27% (+2,790,000)
|
|||
|
2016 Q4
|
0.22%
|
$21.63
|
new
|
|||
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.